Navigation Links
EpiCept Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference
Date:11/28/2007

iCept's current expectations and are subject to risks and uncertainties that could cause actual results or developments to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Factors that may cause actual results or developments to differ materially include: the risk that Ceplene will not receive regulatory approval or marketing authorization in the EU or that Ceplene, if approved, will not achieve significant commercial success, the risk that Myriad's development of Azixa(TM)* will not be successful, the risk that Azixa will not receive regulatory approval or achieve significant commercial success, the risk that EpiCept will not receive any significant payments under its agreement with Myriad, the risk that the development of the Company's other apoptosis product candidates will not be successful, the risk that its ASAP technology will not yield any successful product candidates, the risk that clinical trials for NP-1 or EPC 2407 will not be successful, that NP-1 or EPC 2407 will not receive regulatory approval or achieve significant commercial success, the risk that the Company's other product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later stage clinical trials, the risk that EpiCept will not obtain approval to market any of its product candidates, the risks associated with reliance on additional outside financing to meet its capital requirements, the risks associated with dependence upon key personnel, the risks associated with reliance on collaborative partners and others for further clinical trials, development, manufacturing and commercialization of its product candidates; the cost, delays and uncertainties associated with its scientific research, product development, clinical trials and regulatory approval process; its history of operating losses since inception; competition; litigation; r
'/>"/>
SOURCE EpiCept Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. EpiCept Corporation to Present at the 2007 BIO InvestorForum
2. EpiCept to Present Preclinical Studies of EPC2407 in Combination With Anti-Angiogenic and Chemotherpeutic Agents at the AACR-NCI-EORTC International Conference
3. EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. EpiCept To Host Third Quarter 2007 Conference Call and Webcast on November 7, 2007
5. EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results
6. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
7. Brooke Franchise Corporation Announces Selected July Results
8. MedThink Communications Retained by NanoBio Corporation
9. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
10. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2015)... 2015 Medicx Media Solutions ... executive Jay Krihak as its head of programmatic ... up its expertise and leadership position in the ... Health sectors. , Krihak is an experienced, award-winning ... Krihak led sales planning teams for mobile platform ...
(Date:5/23/2015)... Newport Beach, CA (PRWEB) May 23, 2015 ... Newport Beach, California, has just posted a new article ... ear gauge repair. As Dr Benvenuti explained in ... who wear enlarged plugs in their earlobes. , Known as ... into the earlobe hole, which Dr. Benvenuti said will eventually ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 A live auction ... equipment from hospitals, surgery centers and other medical facilities around ... sold including endoscopy, lab, radiology, surgery, anesthesia, exam and much ... May 27 and Thursday, May 28 starting at 9:00am CDT ... at 1400 N. 25th Avenue, Melrose Park, IL 60160. ...
(Date:5/22/2015)... May 22, 2015 Pioneer Millworks, the ... the forefront of designing with reclaimed wood, introducing their ... Los Angeles, California. Their newest offerings, Vat 35, ... surface and color to America's largest design event. , ... at each show, anxious to see and feel the ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Following yesterday’s ... sale agreement with US-based health brand Nature’s Way, Marc ... brand. Retention of Ascenta Skin is an integral part ... excited about this opportunity to further develop Ascenta Skin ... , Ascenta Skin is a breakthrough, anti-aging skincare supplement ...
Breaking Medicine News(10 mins):Health News:Medicx Media Solutions Expands Executive Team 2Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3Health News:Ascenta Skin President Announces Plans to Grow Brand 2
... use of a surgical frame around a degenerated joint to ... stage osteoarthritis (OA) of the knee, as demonstrated for the ... Annual Congress of the European League Against Rheumatism in Paris, ... with springs, was used to bridge the knee joint in ...
... studies indicate that there is virtually no link between ... children and teens. The meta-analysis is published in ... Clinical Nutrition . , "My co-authors and I carefully ... that there is virtually no association between sugar-sweetened beverage ...
... Urges Congress to Preserve ... Compassionate End-of-Life Care, WASHINGTON, June 13 In ... (MedPAC),reported that the rapid growth of the Medicare hospice benefit was ... per,beneficiary. According to the report, "Evaluating Medicare,s Hospice,Benefit," much more data ...
... in the ongoing salmonella outbreak , , FRIDAY, June 13 ... illnesses from salmonella-tainted tomatoes continued to climb, U.S. health ... the contamination. , The number of people sickened in ... with 25 hospitalizations, health officials announced Thursday. Six more ...
... during the first year of life are a marker ... later in life, according to new research from Sweden ... the European League Against Rheumatism in Paris, France. Researchers ... who were hospitalised for infection before their first birthday ...
... 2008: New data presented today at EULAR 2008, ... in Paris, France, show that intake of oily fish ... arthritis (RA), whereas psychosocial work stress and smoking can ... all taken from a large population-based case-control study in ...
Cached Medicine News:Health News:Joint distraction promotes structural repair in patients with severe knee osteoarthritis 2Health News:More Data Needed Before Changing Medicare Hospice Funding, Report Finds 2Health News:More Data Needed Before Changing Medicare Hospice Funding, Report Finds 3Health News:Source of Contaminated Tomatoes Still Unknown: FDA 2Health News:Source of Contaminated Tomatoes Still Unknown: FDA 3Health News:Source of Contaminated Tomatoes Still Unknown: FDA 4Health News:Early life infections increase the risk of rheumatoid arthritis and juvenile idiopathic arthritis 2Health News:Oily fish can protect against RA, but smoking and psychosocial stress increase its risk 2
(Date:5/22/2015)... 22, 2015 The leading companies in ... global cardiac rhythm management device market dominate their ... Medtronic, St. Jude Medical, Boston Scientific and Asahi ... market segment. The healthcare market research publisher,s report, ... 2015 as a base year, providing forecasts for ...
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, ... announced a peer-reviewed publication of the results of ... RGN-259 (RegeneRx,s preservative-free eye drops) for the treatment ... adverse environment (CAE ® ) model.  The exploratory ... results, which were previously disseminated by the Company ...
(Date:5/22/2015)... 22, 2015 Research and Markets ... the "Latest Regulations on Pharmaceutical International Multi-Center ... offering. This is first time in ... on international multi-center clinical trials of drugs in ... to be implemented on March 1, 2015. The ...
Breaking Medicine Technology:Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 42015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... The Featured Products are ... Mediflex and are offered ... in regular or extra ... equipped with insulation, flush ...
... The Featured Products ... at Mediflex and are ... modular in regular or ... come equipped with insulation, ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... Instruments incorporate a layered design unique in ... monitored to prevent stray electrosurgical burns along ... insulation failure or capacitive coupling; a well-documented ... into all AEM Instruments provides a neutral ...
Medicine Products: